Mestranol/norethisterone

Not to be confused with Mestranol/noretynodrel.
Mestranol/norethisterone
Combination of
MestranolEstrogen
NorethisteroneProgestogen
Clinical data
Trade namesNorethin, Noriday, Norinyl, Norquen, Ortho-Novum, others
AHFS/Drugs.comMonograph
Routes of
administration		By mouth
ATC code
  • None
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
CompTox Dashboard (EPA)

Mestranol/norethisterone (brand names Norethin, Noriday, Norinyl, Norquen, Ortho-Novum, others) is a combination of the estrogen Mestranol and the progestin norethisterone (norethindrone) which was introduced in 1963 and was the second combined oral contraceptive to be marketed, following mestranol/noretynodrel in 1960.[1] Although most mestranol-containing oral contraceptive formulations have been discontinued, the combination remains available today in the United States in a single formulation under the brand name Norinyl 1+50 28-Day.[2] It has largely been superseded by ethinylestradiol/norethisterone, which has been marketed under many of the same brand names.[3][4]

See also

References

  1. ^ Marks L (2010). Sexual Chemistry: A History of the Contraceptive Pill. Yale University Press. pp. 74, 76. ISBN 978-0-300-16791-7.
  2. ^ "Drugs@FDA: FDA Approved Drug Products". United States Food and Drug Administration. Retrieved 22 December 2016.
  3. ^ Blum RW (22 October 2013). Adolescent Health Care: Clinical Issues. Elsevier Science. pp. 216–. ISBN 978-1-4832-7738-7.
  4. ^ Varney H, Kriebs JM, Gegor CL (2004). Varney's Midwifery. Jones & Bartlett Learning. pp. 515–. ISBN 978-0-7637-1856-5.



This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.